Moderna (MRNA) Prepaid Assets (2017 - 2026)

Moderna (MRNA) has reported Prepaid Assets for 10 consecutive years, with $380.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Prepaid Assets fell 50.26% year-over-year to $380.0 million in Q2 2026; TTM through Jun 2026 was $380.0 million, a 50.26% decrease from a year earlier, with the FY2025 full-year figure at $408.0 million, down 31.89% from the prior year.
• Prepaid Assets was $380.0 million for Q2 2026 at Moderna, up from $348.0 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $1.4 billion in Q1 2023 and troughed at $348.0 million in Q1 2026.
• A 5-year average of $804.0 million and a median of $740.0 million in 2025 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets jumped 324.24% in 2022 and tumbled 52.36% in 2024, its largest moves.
• Over 5 years, Prepaid Assets stood at $1.2 billion in 2022, then slumped by 47.53% to $627.0 million in 2023, then retreated by 4.47% to $599.0 million in 2024, then slumped by 31.89% to $408.0 million in 2025, then dropped by 6.86% to $380.0 million in 2026.
• The last three Prepaid Assets figures came in at $380.0 million (Q2 2026), $348.0 million (Q1 2026), and $408.0 million (Q4 2025), per Business Quant data.